Yuhan Corporation
000100
Peringkat dalam Saham
#3833
Yuhan Corporation, a prominent South Korean pharmaceutical firm established in... Yuhan Corporation, a prominent South Korean pharmaceutical firm established in 1926 and headquartered in Seoul, specializes in the research, development, and manufacture of active pharmaceutical ingredients (APIs) and intermediates for both domestic and international markets. Its extensive product portfolio encompasses a wide array of prescription pharmaceuticals (ETC), addressing therapeutic areas such as cardiovascular, alimentary, genito-urinary, metabolic, respiratory, allergy, and neurological systems, alongside anti-infectives, anti-cancer treatments, and hormonal therapies. Notable offerings include Revanex, an acid pump antagonist designed for treating peptic ulcers and gastritis-related mucosal injury. Beyond prescription drugs, Yuhan Corporation provides a diverse range of over-the-counter (OTC) medications, including vitamins, mineral supplements, hepatopathy treatments, tonics, and drugs for respiratory, alimentary, dermatological, and pain relief applications. The company also extends its reach into consumer health and household goods, producing items like bleaches, detergents, pesticides, and oral care products. Further diversifying its operations, Yuhan is involved in the dental sector, supplying implants, equipment, consumables, and dental care solutions, and manufactures veterinary medical supplies for livestock, aquatic species, and companion animals. Additionally, it offers contract manufacturing services to other businesses.
Harga Saham
$63.22
Kapitalisasi Pasar
$4.27B
Perubahan (1 hari)
-3.12%
Perubahan (1 tahun)
-23.57%
Negara
KR
Perdagangan Yuhan Corporation (000100)
Kategori
Healthcare
Margin Operasi untuk Yuhan Corporation (000100)
Margin Operasi per October 2026 TTM: 5.46%
Menurut laporan keuangan dan harga saham terbaru dari Yuhan Corporation, margin operasi saat ini (TTM) adalah 5.46%. Pada akhir 2024, margin operasi perusahaan adalah 2.65%.
Riwayat margin operasi untuk Yuhan Corporation dari 2007 hingga 2026
Margin Operasi pada akhir setiap tahun
| Tahun | Margin Operasi | Mengubah |
|---|---|---|
| 2026 (TTM) | 5.46% | -3.36% |
| 2025 | 5.65% | 113.21% |
| 2024 | 2.65% | -33.92% |
| 2023 | 4.01% | 97.54% |
| 2022 | 2.03% | -29.51% |
| 2021 | 2.88% | -44.62% |
| 2020 | 5.20% | 19.82% |
| 2019 | 4.34% | 31.52% |
| 2018 | 3.30% | -45.63% |
| 2017 | 6.07% | -17.97% |
| 2016 | 7.40% | -2.63% |
| 2015 | 7.60% | 3.97% |
| 2014 | 7.31% | 11.60% |
| 2013 | 6.55% | 46.86% |
| 2012 | 4.46% | -38.23% |
| 2011 | 7.22% | -42.01% |
| 2010 | 12.45% | -6.74% |
| 2009 | 13.35% | -1.69% |
| 2008 | 13.58% | -6.47% |
| 2007 | 14.52% | 0.00% |
Margin Operasi untuk perusahaan sejenis atau pesaing
| Perusahaan | Margin Operasi | Perbedaan Margin Operasi | Negara |
|---|---|---|---|
| 19.41% | -96.45% |
DE
|
|
| 19.68% | -96.40% |
DE
|
|
| 10.52% | -98.07% |
JP
|
|
| 17.08% | -96.87% |
CH
|
|
| 22.93% | -95.80% |
IN
|
Apa itu Margin Operasi perusahaan?
Margin Operasi adalah indikator utama untuk menilai profitabilitas suatu perusahaan. Margin Operasi yang lebih tinggi umumnya lebih baik karena menunjukkan bahwa perusahaan mampu menjual produk atau layanan mereka dengan harga yang jauh lebih tinggi daripada biaya produksinya. Margin Operasi dihitung dengan membagi laba perusahaan dengan pendapatannya.